Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency)
- PMID: 11919209
- PMCID: PMC1769636
- DOI: 10.1136/jcp.55.4.266
Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency)
Abstract
Hereditary angio-oedema is characterised by recurrent swellings in any part of the body and also by recurrent attacks of severe abdominal pain. The disease is inherited in an autosomal dominant manner but up to 25% of cases can occur as a spontaneous mutation. Attacks of swelling can be precipitated by trauma, certain drugs, and emotional stress. Treatment usually involves a combination of prophylaxis, using androgens or antifibrolytic drugs, and replacement with C'1 esterase inhibitor concentrate for acute attacks and before surgery or other traumatic procedures.
References
-
- Tosi M. Molecular genetics of C`1-inhibitor. Immunobiology 1998;199:358–65. - PubMed
-
- Prada AE, Zahedi K, Davis AE. Regulation of C`1-inhibitor synthesis. Immunobiology 1998;199:377–88. - PubMed
-
- Cullmen W, Opferkuck W. Deficiencies in regulator proteins l. C`-1 inhibitor. Progress in Allergy 1986;39:311–34. - PubMed
-
- Johnson AM, Alper CA, Rosen FS, et al. C`-1 inhibitor: evidence for decreased hepatic synthesis in hereditary angioedema. Science 1971;173:553–4. - PubMed
-
- Cicardi M, Bergamaschini L, Cugno M, et al. Pathogenic and clinical aspects of C`-1 inhibitor deficiency. Immunobiology 1998;199:366–76. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources